BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
2049 results:

  • 1. Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application.
    Fan S; Zhou L; Zhang W; Wang D; Tang D
    Cell Commun Signal; 2024 Apr; 22(1):232. PubMed ID: 38637851
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
    Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
    Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of emt by CAFs.
    Bogdanova DA; Kolosova ED; Pukhalskaia TV; Levchuk KA; Demidov ON; Belotserkovskaya EV
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612842
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production.
    Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
    BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
    Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
    Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer.
    Rong Z; Zheng K; Chen J; Jin X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):154. PubMed ID: 38521878
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Bis-arylidene oxindoles for colorectal cancer nanotherapy.
    Bhattacharyya T; Mishra T; Das D; Adhikari SS; Banerjee R
    Bioorg Chem; 2024 May; 146():107294. PubMed ID: 38507997
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
    Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
    Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Decreased interleukin-17RA expression is associated with good prognosis in patients with colorectal cancer and inhibits tumor growth and vascularity in mice.
    Jiang JK; Lin CH; Chang TA; Lo LC; Lin CP; Lu RH; Yang CY
    Cancer Med; 2024 Mar; 13(5):e7059. PubMed ID: 38491831
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Canonical DDR activation by emt inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
    Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
    Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. cancer-derived exosomal Alu RNA promotes colorectal cancer progression.
    Magliacane Trotta S; Adinolfi A; D'Orsi L; Panico S; Mercadante G; Mehlen P; Ambati J; De Falco S; Tarallo V
    Exp Mol Med; 2024 Mar; 56(3):700-710. PubMed ID: 38486106
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A comprehensive review of lncRNA CRNDE in cancer progression and pathology, with a specific glance at the epithelial-mesenchymal transition (emt) process.
    Jasim SA; Al-Hawary SIS; Hjazi A; Ahmad I; Kaur I; Kadhum WR; Alkhafaji AT; Ghildiyal P; Jawad MA; Alsaadi SB
    Pathol Res Pract; 2024 Apr; 256():155229. PubMed ID: 38484655
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A comprehensive multi-omics analysis identifies a robust scoring system for cancer-associated fibroblasts and intervention targets in colorectal cancer.
    Wang F; Li Z; Xu T; Zhang Q; Ma T; Li S; Wang X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):124. PubMed ID: 38478111
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Deubiquitinase BRCC3 promotes the migration, invasion and emt progression of colon adenocarcinoma by stabilizing MET expression.
    Feng X; He S; Chen Y; Zhang L
    Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. SERPINB5 promotes colorectal cancer invasion and migration by promoting emt and angiogenesis via the TNF-α/NF-κB pathway.
    Liu BX; Xie Y; Zhang J; Zeng S; Li J; Tao Q; Yang J; Chen Y; Zeng C
    Int Immunopharmacol; 2024 Apr; 131():111759. PubMed ID: 38460302
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Arenobufagin inhibits lung metastasis of colorectal cancer by targeting c-MYC/Nrf2 axis.
    Wang M; Hu S; Yang J; Yuan L; Han L; Liang F; Zhang F; Zhao H; Liu Y; Gao N
    Phytomedicine; 2024 May; 127():155391. PubMed ID: 38452690
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cellular senescence is associated with the spatial evolution toward a higher metastatic phenotype in colorectal cancer.
    Park SS; Lee YK; Choi YW; Lim SB; Park SH; Kim HK; Shin JS; Kim YH; Lee DH; Kim JH; Park TJ
    Cell Rep; 2024 Mar; 43(3):113912. PubMed ID: 38446659
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways.
    Liu YF; Feng ZQ; Chu TH; Yi B; Liu J; Yu H; Xue J; Wang YJ; Zhang CZ
    Phytomedicine; 2024 Apr; 126():155462. PubMed ID: 38394734
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Anithiactin D, a Phenylthiazole Natural Product from Mudflat-Derived
    Pulat S; Yang I; Lee J; Hwang S; Zhou R; Gamage CDB; Varlı M; Taş İ; Yang Y; Park SY; Hong A; Kim JH; Oh DC; Kim H; Nam SJ; Kang H
    Mar Drugs; 2024 Feb; 22(2):. PubMed ID: 38393059
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TMEM97 knockdown inhibits 5-fluorouracil resistance by regulating epithelial-mesenchymal transition and ABC transporter expression via inactivating the Akt/mTOR pathway in 5-fluorouracil-resistant colorectal cancer cells.
    Xu Y; Tang Y; Xu Q; He W
    Chem Biol Drug Des; 2024 Feb; 103(2):e14490. PubMed ID: 38388887
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 103.